Medicare Enrolled

Dr. Moez Khorsandi, D.O., FACOS

Urology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1245 WILSHIRE BLVD, Los Angeles, CA 90017
2134822910
In practice since 2006 (19 years)
NPI: 1316987050 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khorsandi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khorsandi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khorsandi

Dr. Moez Khorsandi is an urology physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khorsandi performed 3,883 Medicare services across 1,152 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khorsandi received a total of $2,922 from 26 pharmaceutical and/or device companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khorsandi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 22% volume in CA $2,922 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,883
Medicare services
Top 22% in CA for urology physician
1,152
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~204 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
2,551 $66 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
573 $71 $145
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
166 $78 $300
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
152 $145 $422
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
139 $131 $225
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
94 $287 $590
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
73 $9 $45
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $50 $98
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
50 $109 $176
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
21 $108 $386
New patient office visit, complex (60-74 min) 13 $148 $325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,922
Total received (2018-2024)
Avg $417/year across 7 years
Top 46% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
98
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,603 (89.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$219 (7.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100 (3.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$700
2023
$432
2022
$284
2021
$470
2020
$267
2019
$322
2018
$447

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$244
CVRx, Inc.
$169
Astellas Pharma US Inc
$154
Dornier MedTech America, Inc
$65
PFIZER INC.
$50
COLOPLAST CORP
$18
Top 3 companies account for 81.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$578
Astellas Pharma US Inc
$525
Sumitomo Pharma America, Inc.
$370
Dendreon Pharmaceuticals LLC
$176
CVRx, Inc.
$169
Janssen Biotech, Inc.
$162
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$122
Myovant Sciences Inc.
$105
COMSORT, Inc
$100
Medtronic, Inc.
$94
ABBVIE INC.
$74
Dornier MedTech America, Inc
$65
Olympus Corporation of the Americas
$65
AbbVie Inc.
$46
Coloplast Corp
$40
UROVANT SCIENCES INC
$37
Avadel Specialty Pharmaceuticals, LLC
$35
CooperSurgical, Inc.
$28
AKRIMAX PHARMACEUTICALS, LLC
$28
Progenics Pharmaceuticals, Inc.
$20
Endo Pharmaceuticals Inc.
$18
COLOPLAST CORP
$18
Tolmar, Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$12
Janssen Pharmaceuticals, Inc
$12
Augmenix, Inc.
$11
Top 3 companies account for 50.4% of all-time payments
Associated products mentioned in payments ›
AVYCAZ · BOTOX · Barostim Neo System · Dornier MedTech · ELIGARD · ERLEADA · Erleada · GEMTESA · INTERSTIM · KEYTRUDA · LUPRON DEPOT · LifeVest · Luja Coude · MYRBETRIQ · Noctiva · Non-Gyn Products · ORGOVYX · PROVENGE · PYLARIFY · SPEEDICATH · SpaceOAR · TOVIAZ · VESICARE · XIAFLEX · XTANDI · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Los Angeles?
Compare urology physicians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
409
Per 100K population
4.2
County median income
$87,760
Nearest hospital
PIH HEALTH GOOD SAMARITAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Khorsandi is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Khorsandi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Khorsandi performed 2,551 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khorsandi receive payments from pharmaceutical companies?
Yes. Dr. Khorsandi received a total of $2,922 from 26 companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khorsandi's costs compare to other urology physicians in Los Angeles?
Dr. Khorsandi's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khorsandi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →